Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients.
Acta Oncol
; 56(7): 1023-1026, 2017 07.
Article
in En
| MEDLINE
| ID: mdl-28102094
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxonic Acid
/
Tegafur
/
Drug Substitution
/
Hand-Foot Syndrome
/
Capecitabine
/
Neoplasms
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Acta Oncol
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Netherlands